IMS Magazine — Metabolic Health

The Spring 2026 issue of IMS Magazine explores Metabolic Health.

Read about the work of four scientists at IMS that are leading new avenues of research in metabolic health: 

• Dr. Cynthia Luk — studying fat tissue dysfunction in obesity and diabetes.
• Dr. Herbert Gaisano — investigating the cellular mechanisms behind insulin secretion to understand diabetes.
• Dr. Rodrigo Mansur — exploring the intersection of metabolic health and mood.
• Dr. Subodh Verma — studying the efficacy of GLP-1 agonists on cardiovascular and peripheral arterial diseases.

We are excited to feature Dr. Daniel Drucker, who has redefined the landscape of diabetes and weight-loss management through his groundbreaking work on GLP-1 receptor agonists. In this feature, we explore the collaborative path that led him and others to the development of therapies like semaglutide, and what the future holds for this remarkable therapeutic.

Our viewpoints cover a broad range of topics, from the rapid rise of GLP-1 pharmacologics and questions around their regulation, to evolving definitions of obesity that play a role in our approach to its treatment. In addition, we explore the often-overlooked metabolic consequences of antipsychotic and antidepressant medications and emerging strategies to mitigate them.

This issue also features insightful interviews with Lauren de Freitas, IMS alumna and current Senior Specialist at Ontario Health, and Dr. Mitchell Elliot, a medical oncologist and current IMS student in the PhD program studying liquid biopsies for cancer detection.

Read the full issue.